Every year, millions of newborns undergo routine screening as a preventive strategy to detect inherited disorders before symptoms emerge.

The global HLA typing market is expected to expand at a compound annual growth rate (CAGR) of approximately 6% during the ...

Rising investment in individualized cancer therapies, expanding mRNA and AI-driven antigen discovery platforms, and ...

Key opportunities in the Global Esoteric Testing Market include addressing rising chronic disease rates, demand for molecular diagnostics in personalized medicine, and expanding use of liquid biopsy ...

Qiagen is a consumable molecular diagnostics and life-science tools platform and offers QuantiFERON, QIAstat-Dx, QIAcuity ...

The global liquid biopsy market is experiencing substantial growth, driven by increasing demand for non-invasive diagnostic technologies that detect molecular biomarkers using liquid samples, thus ...

The market for microbiome sample preparation technology presents opportunities driven by demand for personalized medicine, ...

Shares of Qiagen have rebounded after three years following a news report that the provider of biotech workflow solutions was evaluating strategic options, which include a potential sale.

According to MarketsandMarkets, "Advanced Ceramics Market by Material (Alumina, Titanate, Zirconia, Silicon Carbide, Piezo ...

The United States genetic testing market presents lucrative growth opportunities driven by increasing disease prevalence, technological advancements, and supportive regulatory frameworks.

Following the acquisition of Paige in 2025, Tempus launches its new AI-powered, biomarker prediction solution for digital ...